RALEIGH, NC – (BUSINESS WIRE) – Raleigh, NC-based organizations ICE Global Consulting, Inc. (“ICE Global”) and CliniStart, Inc. (“CliniStart”), both providers of global clinical research contracting, investigator budgeting, and site payment administration services, announced today that they have merged, effective May 5, 2022, to create a specialized clinical research study start-up organization that strategically focuses. on the critical areas of trial initiation and study management administration, which have long been underserved.
CliniStart has merged with and into ICE Global to better serve the specific needs of the combined organizations’ Pharmaceutical, Biotech, and CRO customers in order to achieve rapid site activation across the globe.
Brooke Millman-Ice, CEO of ICE Global, stated, “The result of our solutions-driven approach has led to accelerated negotiation timelines, expedited site activations, and yielded positive impacts on patients seeking new treatment options. This, coupled with CliniStart’s transparent and forward-thinking methodology of processing site payments, will enhance our existing site payments service offering. As a result, our combined teams will be able to uniquely position our clients for greater study success while also maintaining excellent relationships with the global sites working on these trials. ”
Samuel Searcy, CEO of CliniStart, stated, “Since the founding of CliniStart in 2020, we have worked to create efficiencies to expedite the start-up phase of clinical trials. Today I am proud to say that we will further improve these efficiencies by teaming up with ICE Global and combining resources and our decades of experience to further reduce the delays in starting a study. We are excited to integrate our organizations and become a key niche partner in the industry. ”
The combined organization will provide international service offerings in the following areas:
Clinical research-related contract negotiations including site and vendor contracts in more than 60 countries;
Global Site and Investigator budget development;
Global Site payment administration; and
Staffing services including temporary placement of in-house attorneys and contracts management personnel.
Mr. Searcy will transition from his current role of CEO and focus his contributions as a member of the board of directors of the combined entity. The organization will continue to serve its clients under the ICE Global Consulting, Inc. name with Brooke Millman-Ice as the CEO.
No financial details of the transaction were disclosed.
About ICE Global Consulting, Inc.
ICE Global Consulting, Inc. is a clinical research consulting company focused on decreasing the site contract and budget negotiation timeline by streamlining the global negotiation process. Through its team of dedicated attorneys and experienced global negotiators, ICE Global delivers timely and high-quality clinical contracts and budgets, allowing its Pharmaceutical and CRO clients to safely turn their attention to other critical areas of study start-up.
The CliniStart team has decades of global experience in negotiating site contracts and managing the investigator payment lifecycle. With our concierge site services approach, we make our globally situated subject matter experts available to sites. Paying investigators on time and keeping them well informed makes it easier to attract and retain top-performing sites and the best talent in the field.
For more information on ICE Global Consulting, Inc., visit their website at https://iceglobalconsulting.com